Coronaviruses are a priority for NIAID. Three forms have emerged over the past two decades. These cause the serious and widespread diseases SARS, MERS, and COVID-19.

Feb 2, 2022 · As the global COVID-19 pandemic continues into its third year, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is focusing on preparing for a range of other viral threats that could cause a public health emergency.

NIAID pandemic preparedness focuses predominantly on viruses that could cause epidemics or pandemics and prioritizes research on prototype-pathogens, representative pathogens from viral families known to infect humans, and high-priority pathogens most likely to …

Feb 2, 2022 · As the global COVID-19 pandemic continues into its third year, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is focusing on preparing for a range of other viral threats that could cause a public health emergency.

Mar 17, 2021 · COVID-19 is a once-in-a-lifetime global infectious disease pandemic requiring an unprecedented public-private research effort. NIAID plays a central and important role in the public health response to COVID-19.

Apr 23, 2020 · A new strategic plan from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, details the institute’s plan for accelerating research to diagnose, prevent and treat COVID-19.

In 2020, the emergence of the novel coronavirus SARS-CoV-2 and the disease it causes, COVID-19, highlighted the importance of the dual mandate of the National Institute of Allergy and Infectious Diseases (NIAID).

Jan 24, 2025 · Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory viruses, has been named acting director of the nearly $50 billion agency.

NIAID also works closely with partners in academia, industry, government, and non-governmental organizations in multifaceted and multidisciplinary efforts to address emerging health challenges such as the H1N1/09 pandemic and the COVID-19 pandemic.

Aug 2, 2023 · Dr. Jeanne Marrazzo has been selected as the next director of the National Institute of Allergy and Infectious Diseases, the National Institutes of Health announced in a news release...